{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:40:17Z","timestamp":1685094017310},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T00:00:00Z","timestamp":1250035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00296-009-0980-x","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T11:58:42Z","timestamp":1249991922000},"page":"461-466","source":"Crossref","is-referenced-by-count":5,"title":["A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Elham","family":"Aflaky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Shenavandeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,12]]},"reference":[{"key":"980_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","volume":"4","author":"MA Boekel Van","year":"2002","unstructured":"Van Boekel MA, Vossenaar ER, Van den Hoogen FH, Van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87\u201393. doi: 10.1186\/ar395","journal-title":"Arthritis Res"},{"issue":"Suppl 2","key":"980_CR2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G Steiner","year":"2002","unstructured":"Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(Suppl 2):S1\u2013S5. doi: 10.1186\/ar551","journal-title":"Arthritis Res"},{"key":"980_CR3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","volume":"62","author":"DM Lee","year":"2003","unstructured":"Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870\u2013874. doi: 10.1136\/ard.62.9.870","journal-title":"Ann Rheum Dis"},{"key":"980_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/art.1780230611","volume":"23","author":"ME Weinblatt","year":"1980","unstructured":"Weinblatt ME, Schur PH (1980) Rheumatoid factor detection by nephelometry. Arthritis Rheum 23:777\u2013779. doi: 10.1002\/art.1780230611","journal-title":"Arthritis Rheum"},{"key":"980_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","volume":"47","author":"A Saraux","year":"2002","unstructured":"Saraux A, Berthelot JM, Chales G, Le Henaff C, Mary JY, Thorel V et al (2002) Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 47:155\u2013165. doi: 10.1002\/art.10241","journal-title":"Arthritis Rheum"},{"key":"980_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/ard.61.6.505","volume":"61","author":"S Bas","year":"2002","unstructured":"Bas S, Perneger TV, Kunzle E, Vischer TL (2002) Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis 61:505\u2013510. doi: 10.1136\/ard.61.6.505","journal-title":"Ann Rheum Dis"},{"key":"980_CR7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089\u20131093","journal-title":"Clin Chem"},{"key":"980_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163. doi: 10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","journal-title":"Arthritis Rheum"},{"key":"980_CR9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","volume":"40","author":"M Meltzer","year":"1966","unstructured":"Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia\u2014a clinical and laboratory study. Am J Med 40:837\u2013856. doi: 10.1016\/0002-9343(66)90200-2","journal-title":"Am J Med"},{"key":"980_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0021-9681(67)90009-4","volume":"20","author":"WM Mikkelsen","year":"1967","unstructured":"Mikkelsen WM, Dodge HJ, Duff IF, Kato H (1967) Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959\u20131960. J Chronic Dis 20:351\u2013369. doi: 10.1016\/0021-9681(67)90009-4","journal-title":"J Chronic Dis"},{"key":"980_CR11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7326\/0003-4819-52-5-1059","volume":"52","author":"H Bartfeld","year":"1960","unstructured":"Bartfeld H (1960) Incidence and significance of seropositive tests for rheumatoid factor in non-rheumatoid disease. Ann Intern Med 52:1059\u20131066","journal-title":"Ann Intern Med"},{"key":"980_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, De Jong BA, Van Den Hoogen FH, Van De Putte LB, Van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 101:273\u2013281. doi: 10.1172\/JCI1316","journal-title":"J Clin Invest"},{"key":"980_CR13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C et al (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585\u2013594","journal-title":"J Immunol"},{"key":"980_CR14","doi-asserted-by":"crossref","unstructured":"Pruijn GJ, M Vossenaarl ER, Drijfhout J, van Venrooij WJ, Zendman AJ (2005) Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis. Curr Rheumatol Rep 1:1\u20137. doi: 10.2174\/1573397052954208","DOI":"10.2174\/1573397052954208"},{"key":"980_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/rheumatology\/33.8.765","volume":"33","author":"P Emery","year":"1994","unstructured":"Emery P (1994) The optimal management of early rheumatoid disease: the diagnostic performances of Anti-CCP and AFA. Br J Rheumatol 33:765\u2013768. doi: 10.1093\/rheumatology\/33.8.765","journal-title":"Br J Rheumatol"},{"key":"980_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ard.2003.010298","volume":"63","author":"J Aken van","year":"2004","unstructured":"van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TWJ (2004) Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 63:274\u2013279. doi: 10.1136\/ard.2003.010298","journal-title":"Ann Rheum Dis"},{"key":"980_CR17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VP Nell","year":"2004","unstructured":"Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43:906\u2013914. doi: 10.1093\/rheumatology\/keh199","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"980_CR18","first-page":"1510","volume":"64","author":"FA Gaalen van","year":"2005","unstructured":"van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first- and second anti-cyclic citrullinated peptides autoantibody (CCP1 and CCP2). Tests Rheumatoid Arthritis Ann Rheum Dis 64(10):1510\u20131512. doi: 10.1136\/ard.2004.035089","journal-title":"Tests Rheumatoid Arthritis Ann Rheum Dis"},{"key":"980_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","volume":"63","author":"S Dubucquoi","year":"2004","unstructured":"Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J et al (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63:415\u2013419. doi: 10.1136\/ard.2003.008623","journal-title":"Ann Rheum Dis"},{"key":"980_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324. doi: 10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"issue":"3","key":"980_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.55.3.157","volume":"55","author":"H Visser","year":"1996","unstructured":"Visser H, Gelinck LB, Kampfraath AH, Breedveld FC, Hazes (1996) Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid J M factor assays in rheumatoid arthritis. Ann Rheum Dis 55(3):157\u2013161. doi: 10.1136\/ard.55.3.157","journal-title":"Ann Rheum Dis"},{"key":"980_CR22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/rheumatology\/kei228","volume":"45","author":"OMR Westwood","year":"2006","unstructured":"Westwood OMR, Nelsonl PN, Hay FC (2006) Review. Rheumatoid factors: what\u2019s new? Rheumatology 45:379\u2013385. doi: 10.1093\/rheumatology\/kei228","journal-title":"Rheumatology"},{"issue":"4","key":"980_CR23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","volume":"45","author":"MA Quinn","year":"2006","unstructured":"Quinn MA, Gough AKS, Green MJ, Devlin J, Hensor EMA, Greensteinet A et al (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology 45(4):478\u2013480. doi: 10.1093\/rheumatology\/kei203","journal-title":"Rheumatology"},{"issue":"11","key":"980_CR31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1515\/CCLM.2005.214","volume":"43","author":"A Fernandez-Suarez","year":"2005","unstructured":"Fernandez-Suarez A, Reneses S, Wichmann I, Criado R, Nunez A (2005) Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med 43(11):1234\u20131239. doi: 10.1515\/CCLM.2005.214","journal-title":"Clin Chem Lab Med"},{"key":"980_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cair.2003.11.001","volume":"4","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, van Venrooij WJ (2004) Anti-CCP antibodies, a specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 4:239\u2013262. doi: 10.1016\/j.cair.2003.11.001","journal-title":"Clin Appl Immunol Rev"},{"key":"980_CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/ard.60.5.459","volume":"60","author":"L Vasiliauskiene","year":"2001","unstructured":"Vasiliauskiene L, Wiik A, Hoier-Madsen M (2001) Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 60:459\u2013466. doi: 10.1136\/ard.60.5.459","journal-title":"Ann Rheum Dis"},{"key":"980_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236\u2013243. doi: 10.1186\/ar93","journal-title":"Arthritis Res"},{"key":"980_CR27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/ard.2003.019331","volume":"63","author":"O Kasapcopur","year":"2004","unstructured":"Kasapcopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-G\u00f6ksel A, Saribas S et al (2004) Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 63:1687\u20131689. doi: 10.1136\/ard.2003.019331","journal-title":"Ann Rheum Dis"},{"key":"980_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3346\/jkms.2005.20.3.473","volume":"20","author":"SW Choi","year":"2005","unstructured":"Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473\u2013478","journal-title":"J Korean Med Sci"},{"key":"980_CR29","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2005.035444","volume":"64","author":"IK Gao","year":"2005","unstructured":"Gao IK, Haas-Wohrle A, Mueller KG, Lorenz HM, Fiehn C (2005) Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist? Ann Rheum Dis 64:1516\u20131517. doi: 10.1136\/ard.2005.035444","journal-title":"Ann Rheum Dis"},{"key":"980_CR30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3\u00a0years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085\u20131089. doi: 10.1136\/ard.2003.016808","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-0980-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0980-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:01:26Z","timestamp":1685091686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-0980-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-0980-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,12]]}}}